2023 Q3 Form 10-Q Financial Statement

#000165495423014609 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q3
Revenue $6.126M $6.121M $8.059M
YoY Change -23.99% -0.94% 29.48%
Cost Of Revenue $4.643M $4.930M $6.086M
YoY Change -23.71% -2.34% 608500.0%
Gross Profit $1.483M $1.191M $1.973M
YoY Change -24.84% 5.31% 31.62%
Gross Profit Margin 24.21% 19.46% 24.48%
Selling, General & Admin $1.515M $1.299M $1.310M
YoY Change 15.65% 7.09% 18.55%
% of Gross Profit 102.16% 109.07% 66.4%
Research & Development $32.72K $30.95M
YoY Change -99.89% 9.28%
% of Gross Profit 2.21% 1568.68%
Depreciation & Amortization $99.22K $90.00K $86.86K
YoY Change 14.24% 13.92% 22.87%
% of Gross Profit 6.69% 7.56% 4.4%
Operating Expenses $1.515M $1.389M $1.397M
YoY Change 8.45% 7.51% 18.79%
Operating Profit -$32.00K -$198.0K $576.0K
YoY Change -105.56% 22.98% 78.33%
Interest Expense -$94.00K -$93.00K -$84.00K
YoY Change 11.9% 14.81% -12.5%
% of Operating Profit -14.58%
Other Income/Expense, Net -$94.00K -$84.00K
YoY Change 11.9% -12.5%
Pretax Income -$126.0K -$291.0K $492.0K
YoY Change -125.61% 20.25% 116.74%
Income Tax $0.00 -$10.00K $0.00
% Of Pretax Income 0.0%
Net Earnings -$126.0K -$281.0K $492.0K
YoY Change -125.61% 16.12% 116.74%
Net Earnings / Revenue -2.06% -4.59% 6.1%
Basic Earnings Per Share $0.00 $0.01
Diluted Earnings Per Share $0.00 $0.00 $0.01
COMMON SHARES
Basic Shares Outstanding 76.55M shares 76.55M shares 76.05M shares
Diluted Shares Outstanding 76.55M shares 76.63M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.138M $1.041M $1.348M
YoY Change -15.58% 21.19% 40.27%
Cash & Equivalents $1.138M $1.041M $1.348M
Short-Term Investments
Other Short-Term Assets $122.0K $84.00K $190.0K
YoY Change -35.79% -49.09% 19.5%
Inventory $4.055M $4.202M $3.660M
Prepaid Expenses $122.0K $84.00K $190.0K
Receivables $1.169M $1.051M $1.481M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.484M $6.378M $6.679M
YoY Change -2.92% 7.23% 16.97%
LONG-TERM ASSETS
Property, Plant & Equipment $2.142M $2.186M $1.975M
YoY Change 8.46% 7.74% 3.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.00K $110.0K $99.00K
YoY Change -13.13% 10.0% 4.21%
Total Long-Term Assets $4.069M $4.233M $4.283M
YoY Change -5.0% -4.47% -5.18%
TOTAL ASSETS
Total Short-Term Assets $6.484M $6.378M $6.679M
Total Long-Term Assets $4.069M $4.233M $4.283M
Total Assets $10.55M $10.61M $10.96M
YoY Change -3.73% 2.24% 7.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.178M $2.114M $2.700M
YoY Change -19.33% -21.12% -0.92%
Accrued Expenses $565.0K $416.0K $788.0K
YoY Change -28.3% -23.67% 34.93%
Deferred Revenue
YoY Change
Short-Term Debt $1.112M $1.252M $1.367M
YoY Change -18.65% -3.32% 22.71%
Long-Term Debt Due $400.0K $407.0K $446.0K
YoY Change -10.31% 26.01% 42.95%
Total Short-Term Liabilities $4.666M $4.585M $5.654M
YoY Change -17.47% -11.38% 12.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.253M $1.148M $881.0K
YoY Change 42.22% -2.96% -33.61%
Other Long-Term Liabilities $1.557M $1.667M $1.969M
YoY Change -20.92% -19.39% -15.89%
Total Long-Term Liabilities $2.810M $2.815M $2.966M
YoY Change -5.26% -13.41% -19.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.666M $4.585M $5.654M
Total Long-Term Liabilities $2.810M $2.815M $2.966M
Total Liabilities $7.476M $7.400M $8.504M
YoY Change -12.09% -12.17% -1.95%
SHAREHOLDERS EQUITY
Retained Earnings -$3.916M -$3.790M -$4.497M
YoY Change -12.92% -24.03% -16.19%
Common Stock $765.0K $765.0K $760.0K
YoY Change 0.66% 0.66% 1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.077M $3.211M $2.458M
YoY Change
Total Liabilities & Shareholders Equity $10.55M $10.61M $10.96M
YoY Change -3.73% 2.24% 7.19%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q3
OPERATING ACTIVITIES
Net Income -$126.0K -$281.0K $492.0K
YoY Change -125.61% 16.12% 116.74%
Depreciation, Depletion And Amortization $99.22K $90.00K $86.86K
YoY Change 14.24% 13.92% 22.87%
Cash From Operating Activities $172.0K -$245.0K $617.0K
YoY Change -72.12% -297.58% 265.09%
INVESTING ACTIVITIES
Capital Expenditures $32.00K $2.000K $21.00K
YoY Change 52.38% -200.0% -65.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$32.00K -$2.000K -$21.00K
YoY Change 52.38% 0.0% -58.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$43.00K -65.00K -$107.0K
YoY Change -59.81% -67.17% -20.74%
NET CHANGE
Cash From Operating Activities $172.0K -245.0K $617.0K
Cash From Investing Activities -$32.00K -2.000K -$21.00K
Cash From Financing Activities -$43.00K -65.00K -$107.0K
Net Change In Cash $97.00K -312.0K $489.0K
YoY Change -80.16% 310.53% -3156.25%
FREE CASH FLOW
Cash From Operating Activities $172.0K -$245.0K $617.0K
Capital Expenditures $32.00K $2.000K $21.00K
Free Cash Flow $140.0K -$247.0K $596.0K
YoY Change -76.51% -296.03% 451.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1557000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2810000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
7476000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6228000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6234000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3916000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3790000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3211000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10611000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
99000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3077000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
765000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10553000 usd
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001374567
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Security12g Title
Security12gTitle
Common Stock, $.01 par value
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Atlanta
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76547672 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76547672 shares
CY2023Q3 luvu Shares Of Common Stock Reserved For Issuance Under The2015 Stock Option Plan
SharesOfCommonStockReservedForIssuanceUnderThe2015StockOptionPlan
1450000 shares
CY2011Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-53314
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
Luvu Brands, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3581576
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2745 Bankers Industrial Drive
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30360
CY2023Q3 dei City Area Code
CityAreaCode
770
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
246-6400
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76547672 shares
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1667000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2815000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
7400000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76547672 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76547672 shares
CY2023Q3 us-gaap Revenues
Revenues
6126000 usd
CY2022Q3 us-gaap Revenues
Revenues
8059000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4643000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6173000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1483000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1886000 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
269000 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
187000 usd
CY2023Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
427000 usd
CY2022Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
365000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
819000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
758000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1515000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1310000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
576000 usd
CY2023Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
94000 usd
CY2022Q3 us-gaap Financing Interest Expense
FinancingInterestExpense
84000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-94000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-84000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-126000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
492000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-126000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
492000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76547672 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76046249 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76547672 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76632738 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1954000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
492000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2458000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3211000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
-6000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-126000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3077000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-126000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
492000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
87000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
-6000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
93000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
81000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-119000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-290000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
147000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
158000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-36000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-25000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20000 usd
CY2023Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
155000 usd
CY2022Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
110000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
48000 usd
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-94000 usd
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-77000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
172000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
617000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000 usd
CY2023Q3 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
200000 usd
CY2022Q3 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
0 usd
CY2023Q3 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
200000 usd
CY2022Q3 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2023Q3 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 usd
CY2022Q3 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
0 usd
CY2023Q3 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
63000 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-25000 usd
CY2023Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3000 usd
CY2022Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3000 usd
CY2023Q3 luvu Payments On Equipment Notes
PaymentsOnEquipmentNotes
99000 usd
CY2022Q3 luvu Payments On Equipment Notes
PaymentsOnEquipmentNotes
76000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-107000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
97000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
489000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1041000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
859000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1138000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
94000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
83000 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 luvu Consolidated Sales Percentage
ConsolidatedSalesPercentage
0.10 pure
CY2023Q2 luvu Allowance For Discounts And Returns
AllowanceForDiscountsAndReturns
-55000 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
1169000 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1051000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4055000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
4202000 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 35.45pt; text-align:left;"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period.  Significant estimates in these consolidated financial statements include estimates of: income taxes; tax valuation allowance; allowances for doubtful accounts; inventory valuation and allowance; share-based compensation; and useful lives for depreciation and amortization. Actual results could differ materially from these estimates.   </p>
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
18754 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
137821 usd
CY2023Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1177000 usd
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1107000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1000 usd
CY2023Q3 luvu Allowance For Discounts And Returns
AllowanceForDiscountsAndReturns
-6000 usd
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">The Company maintains its cash accounts with banks located in Georgia.  The total cash balances are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per bank. The Company had bank balances on deposit at September 30, 2023 that exceeded the balance insured by the FDIC by $926,492. Accounts receivable are typically unsecured and are derived from revenue earned from customers primarily located in North America and Europe.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">During the three months ended September, 30 2023, we purchased 35% of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">During the fiscal year ended June 30, 2023, we purchased 35% of total inventory purchases from one vendor.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:left;">As of September 30, 2023, two of the Company’s customers represents 48% and 13% of the total accounts receivables, respectively. As of June 30, 2023, two of the Company’s customers represents 35% and 12% of the total accounts receivables, respectively. For the three months ended September 30, 2023, sales to and through Amazon accounted for 37% of our net sales.</p>
CY2023Q3 us-gaap Cash
Cash
250000 usd
CY2023Q3 luvu Fdic Balance Limit Excess
FdicBalanceLimitExcess
926492 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
268544 usd
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
186994 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
32722 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
30950 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6275000 shares
CY2020Q4 luvu Rental Abatement
RentalAbatement
103230 usd
CY2020Q4 us-gaap Capital Leases Contingent Rental Payments Due
CapitalLeasesContingentRentalPaymentsDue
51615 usd
CY2023Q3 luvu Annual Escalations In Rent
AnnualEscalationsInRent
0.03 pure
CY2020Q4 luvu Final Two Months Rent
FinalTwoMonthsRent
61605 usd
CY2023Q3 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.02 pure
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
163188 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
163188 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5650000 shares
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1777000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1926000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
550000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
507000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1980000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2021000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
4307000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
4454000 usd
CY2023Q3 luvu Allowance For Excess And Obsolete Inventory
AllowanceForExcessAndObsoleteInventory
-252000 usd
CY2023Q2 luvu Allowance For Excess And Obsolete Inventory
AllowanceForExcessAndObsoleteInventory
-252000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6587000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6532000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4445000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4346000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2142000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2186000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
99222 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86856 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
457000 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
302000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
108000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
114000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
565000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
416000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
200000 usd
CY2023Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
400000 usd
CY2023Q2 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
200000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
400000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
400000 usd
CY2023Q3 us-gaap Unsecured Debt
UnsecuredDebt
10000 usd
CY2023Q2 us-gaap Unsecured Debt
UnsecuredDebt
13000 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1102000 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1039000 usd
CY2023Q3 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
0 usd
CY2023Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
200000 usd
CY2023Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
387000 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
392000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
15000 usd
CY2023Q3 luvu Total Current Debt
TotalCurrentDebt
1512000 usd
CY2023Q2 luvu Total Current Debt
TotalCurrentDebt
1659000 usd
CY2023Q3 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
400000 usd
CY2023Q2 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
200000 usd
CY2023Q3 us-gaap Other Notes Payable
OtherNotesPayable
8000 usd
CY2023Q2 us-gaap Other Notes Payable
OtherNotesPayable
9000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
729000 usd
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
824000 usd
CY2023Q3 luvu Notes Payable Related Party Note9
NotesPayableRelatedPartyNote9
116000 usd
CY2023Q2 luvu Notes Payable Related Party Note9
NotesPayableRelatedPartyNote9
116000 usd
CY2023Q3 luvu Total Long Term Debt
TotalLongTermDebt
1253000 usd
CY2023Q2 luvu Total Long Term Debt
TotalLongTermDebt
1148000 usd
CY2023Q3 luvu Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
116000 usd
CY2023Q2 luvu Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
116000 usd
CY2023Q3 luvu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0 usd
CY2023Q2 luvu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0 usd
CY2023Q3 luvu Notes Payable Longtermunsecured Related Party Noncurrent
NotesPayableLongtermunsecuredRelatedPartyNoncurrent
116000 usd
CY2023Q2 luvu Notes Payable Longtermunsecured Related Party Noncurrent
NotesPayableLongtermunsecuredRelatedPartyNoncurrent
116000 usd
CY2023Q3 us-gaap Line Of Credit Facility Collateral
LineOfCreditFacilityCollateral
85% of eligible accounts receivable (as defined in the agreement) for the purpose of improving working capital
CY2023Q3 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
1.25 pure
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.02 pure
CY2023Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.11 pure
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
9608 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12806 usd
CY2023Q3 luvu Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P4Y
CY2023Q3 luvu Weighted Average Discount Rate
WeightedAverageDiscountRate
0.1449 pure
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1820000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
411000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1557000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1968000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
515000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
721000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
762000 usd
CY2023Q3 luvu Lessee Operating Lease Liability Payments Due After Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour
528000 usd
CY2023Q3 luvu Total Undiscounted Lease Payments
TotalUndiscountedLeasePayments
2526000 usd
CY2023Q3 luvu Less Present Value Discount
LessPresentValueDiscount
-558000 usd
CY2023Q3 luvu Total Lease Liability Balance
TotalLeaseLiabilityBalance
1968000 usd
CY2023Q3 luvu Equipment Notes Payable
EquipmentNotesPayable
2290061 usd
CY2023Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
351000 usd
CY2023Q3 luvu Contractual Obligation Due In Fourth Year5
ContractualObligationDueInFourthYear5
427000 usd
CY2023Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
309000 usd
CY2023Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
130000 usd
CY2023Q3 luvu Contractual Obligation Duesixth Year
ContractualObligationDuesixthYear
39000 usd
CY2023Q3 luvu Future Minimum Lease Payments
FutureMinimumLeasePayments
1256000 usd
CY2023Q3 luvu Amount Representing Interest
AmountRepresentingInterest
-140000 usd
CY2023Q3 luvu Contractual Obligation8
ContractualObligation8
1116000 usd
CY2023Q3 luvu Other Note Payable Current
OtherNotePayableCurrent
-387000 usd
CY2023Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
729000 usd
CY2023Q3 luvu Contractual Obligation Due In Third Year2
ContractualObligationDueInThirdYear2
12000 usd
CY2023Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
6000 usd
CY2023Q3 luvu Contractual Obligation Due In Fifth Year6
ContractualObligationDueInFifthYear6
3000 usd
CY2023Q3 luvu Future Minimum Finance Lease Payable Payments
FutureMinimumFinanceLeasePayablePayments
21000 usd
CY2023Q3 luvu Amount Representing Interest7
AmountRepresentingInterest7
-1000 usd
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
20000 usd
CY2023Q3 luvu Other Note Payable Current3
OtherNotePayableCurrent3
-13000 usd
CY2023Q3 luvu Other Notes Payable1
OtherNotesPayable1
8000 usd
CY2023Q3 luvu Annual Base Salary
AnnualBaseSalary
155000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1450000 shares
CY2023Q3 luvu Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberbegining Balance
SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberbeginingBalance
1400000 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2023Q3 luvu Weighted Average Exercise Price Outstanding Begining Balance
WeightedAverageExercisePriceOutstandingBeginingBalance
0.14
CY2023Q2 luvu Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
200000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
3760
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
250000 shares
CY2023Q3 luvu Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber Ending Balance
SharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberEndingBalance
1350000 shares
CY2023Q3 luvu Weighted Average Remaining Contractual Life Ending
WeightedAverageRemainingContractualLifeEnding
P2Y2M12D
CY2023Q3 luvu Weighted Average Exercise Price Outstanding Ending Balance
WeightedAverageExercisePriceOutstandingEndingBalance
0.10
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
32760 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
550000 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y10M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
23500 usd
CY2023Q3 us-gaap Share Price
SharePrice
0.10
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
200000 shares
CY2023Q3 luvu Shares Issued Exercise Price Per Share
SharesIssuedExercisePricePerShare
0.081
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1350000 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.12
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
550000 shares
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
-6000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
12000 usd
CY2023Q3 luvu Stock Option Based Compensation Expense
StockOptionBasedCompensationExpense
15625 usd
CY2023Q3 luvu Unrecognized Stock Expense
UnrecognizedStockExpense
89662 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2023Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4300000 shares
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5750000 shares

Files In Submission

Name View Source Status
luvu-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001654954-23-014609-index-headers.html Edgar Link pending
0001654954-23-014609-index.html Edgar Link pending
0001654954-23-014609.txt Edgar Link pending
0001654954-23-014609-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
luvu-20230930.xsd Edgar Link pending
luvu_10q.htm Edgar Link pending
luvu_ex311.htm Edgar Link pending
luvu-20230930_def.xml Edgar Link unprocessable
luvu-20230930_lab.xml Edgar Link unprocessable
luvu-20230930_pre.xml Edgar Link unprocessable
luvu_10q_htm.xml Edgar Link completed
luvu_ex312.htm Edgar Link pending
luvu_ex321.htm Edgar Link pending
luvu_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending